Uremic albumin blocks reverse cholesterol transfer: role of lysine modifications

por Binder, Veronika, Holzer, Michael, El-Gamal, Dalia, Dirnberger, Sabine, Marsche, Gunther
Publicado 2011

Uremia-induced lysine modifications transform plasma albumin into a high-density lipoprotein receptor inhibitor

por Binder, Veronika, Holzer, Michael, El-Gamal, Dalia, Dirnberger, Sabine, Marsche, Gunther
Publicado 2012

Urea induces intercellular adhesion molecule-1 expression

por El-Gamal, Dalia, Holzer, Michael, Binder, Veronika, Dirnberger, Sabine, Heinemann, Ákos, Marsche, Gunther
Publicado 2011

Defining the Role of the Gut Microbiome in the Pathogenesis and Treatment of Lymphoid Malignancies

por Upadhyay Banskota, Shristi, Skupa, Sydney A., El-Gamal, Dalia, D’Angelo, Christopher R.
Publicado 2023

Uremia alters HDL composition and cholesterol efflux capacity

por Holzer, Michael, Birner-Grünberger, Ruth, Stojaković, Tatjana, El-Gamal, Dalia, Binder, Veronika, Wadsack, Christian, Heinemann, Ákos, Marsche, Gunther
Publicado 2012

Combinatorial inhibition of BTK, PI3K-AKT and BRD4-MYC as a strategy for treatment of mantle cell lymphoma

por Vann, Kendra R., Pal, Dhananjaya, Smith, Audrey L., Sahar, Namood-e, Krishnaiah, Maddeboina, El-Gamal, Dalia, Kutateladze, Tatiana G.
Publicado 2022

The BTK/PI3K/BRD4 axis inhibitor SRX3262 overcomes Ibrutinib resistance in mantle cell lymphoma

por Pal, Dhananjaya, Vann, Kendra R., Joshi, Shweta, Sahar, Namood E., Morales, Guillermo A., El-Gamal, Dalia, Kutateladze, Tatiana G., Durden, Donald L.
Publicado 2021

Insect cell expression and purification of recombinant SARS‐COV‐2 spike proteins that demonstrate ACE2 binding

por Struble, Lucas R., Smith, Audrey L., Lutz, William E., Grubbs, Gabrielle, Sagar, Satish, Bayles, Kenneth W., Radhakrishnan, Prakash, Khurana, Surender, El‐Gamal, Dalia, Borgstahl, Gloria E. O.
Publicado 2022

Bromodomain and Extraterminal Protein Inhibitor, Apabetalone (RVX-208), Reduces ACE2 Expression and Attenuates SARS-Cov-2 Infection In Vitro

por Gilham, Dean, Smith, Audrey L., Fu, Li, Moore, Dalia Y., Muralidharan, Abenaya, Reid, St. Patrick M., Stotz, Stephanie C., Johansson, Jan O., Sweeney, Michael, Wong, Norman C. W., Kulikowski, Ewelina, El-Gamal, Dalia
Publicado 2021

Binding of the SARS-CoV-2 envelope E protein to human BRD4 is essential for infection

por Vann, Kendra R., Acharya, Arpan, Jang, Suk Min, Lachance, Catherine, Zandian, Mohamad, Holt, Tina A., Smith, Audrey L., Pandey, Kabita, Durden, Donald L., El-Gamal, Dalia, Côté, Jacques, Byrareddy, Siddappa N., Kutateladze, Tatiana G.
Publicado 2022

A Novel Triple-Action Inhibitor Targeting B-Cell Receptor Signaling and BRD4 Demonstrates Preclinical Activity in Chronic Lymphocytic Leukemia

por Smith, Audrey L., Eiken, Alexandria P., Skupa, Sydney A., Moore, Dalia Y., Umeta, Lelisse T., Smith, Lynette M., Lyden, Elizabeth R., D’Angelo, Christopher R., Kallam, Avyakta, Vose, Julie M., Kutateladze, Tatiana G., El-Gamal, Dalia
Publicado 2022

Next generation XPO1 inhibitor shows improved efficacy and in vivo tolerability in hematologic malignancies

por Hing, Zachary A., Fung, Ho Yee Joyce, Ranganathan, Parvathi, Mitchell, Shaneice, El-Gamal, Dalia, Woyach, Jennifer A., Williams, Katie, Goettl, Virginia M., Smith, Jordan, Yu, Xueyan, Meng, Xiaomei, Sun, Qingxiang, Cagatay, Tolga, Lehman, Amy M., Lucas, David M., Baloglu, Erkan, Shacham, Sharon, Kauffman, Michael G., Byrd, John C., Chook, Yuh Min, Garzon, Ramiro, Lapalombella, Rosa
Publicado 2016